<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T01:45:37Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/11095" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/11095</identifier><datestamp>2026-09-24T00:10:43Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Nodwell, Justin R</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Wright, Gerry</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Li, Yingfu</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Gverzdys, Tomas A.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:53:34Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:53:34Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2011-08-30</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2011-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/6090</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7116</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2205330</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/11095</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/15237</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>The Gram-positive, soil dwelling bacteria of the genus &lt;em>Streptomyces&lt;/em> produce greater than 50% of the clinically relevant antibiotics in use today. Thanks to the falling price of DNA sequencing, &lt;em>Streptomyces&lt;/em> genomes are revealing that they encode more secondary metabolites (potential antibiotics) than they produce under standard laboratory conditions. By heterologously overexpressing the known pleiotropic regulators of antibiotic expression from &lt;em>Streptomyces coelicolor&lt;/em> in several other &lt;em>Streptomyces&lt;/em> species it has been shown that the secondary metabolite profile of these species can be influenced. While present-day methods of introducing genes (conjugation) and screening for antibiotics work well on a small scale, the low throughput nature of these protocols stand as a barrier to testing this hypothesis on a larger scale. The focus of the research presented here was to develop high throughput (HTP) methods of engineering and screening &lt;em>Streptomyces&lt;/em>. With these two technologies in place, an attempt was to made to introduce three plasmids (pSET152-&lt;em>ermE*&lt;/em>p-null, pSET152-&lt;em>ermE&lt;/em>*p-&lt;em>atrA&lt;/em> and pSET152-&lt;em>ermE&lt;/em>*p-&lt;em>lsr2&lt;sub>NTD&lt;/sub>&lt;/em>) into 120 wild-isolate &lt;em>Streptomyces&lt;/em> species from the Wright Actinomycete Collection. Exconjugants were successfully obtained for all three plasmids in 48 species of &lt;em>Streptomyces&lt;/em> and were screened for increased antimicrobial activity using a HTP, &lt;em>lux&lt;/em>-based bioassay. Numerous strains showed increased antimicrobial activity but WAC00206, WAC00230 and WAC00263 with pSET152-&lt;em>ermE&lt;/em>*p-&lt;em>lsr2&lt;sub>NTD &lt;/sub>&lt;/em>showed the most promising improvement in antimicrobial activity. These hits have been designated as high priority for future investigation. These results suggest that HTP conjugation and the &lt;em>lux&lt;/em>-based bioassay are powerful methods for introducing plasmids into and screening engineered streptomycetes.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">luminescence</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">lux</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">conjugation</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">screening</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">HTP</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">HTS</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biotechnology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The Development of Protocols to Engineer and Screen Streptomyces in High Throughput to Test for the Activation of Cryptic Clusters by the Heterologous Expression of Pleiotropic Regulators</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>